Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 296 participants.
Also called NCT01227616
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 296 participants
- Sponsor
- Registry
-
NCT01227616
-
- Other papers using this trial's data
- Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
- The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01227616. Randomized; no masking; primary purpose treatment. Start 2013-08 (actual); primary completion 2016-02 (actual). Results posted on 2019-07-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
- Condition
- Iron Deficiency Anemia Treatment
- Intervention (Drug)
- Ferumoxytol
- Intervention (Drug)
- Iron Sucrose
- Lead sponsor
- AMAG Pharmaceuticals, Inc.
Record details
- Record id
cardio:ct-nct01227616- Content hash
0afaf356599c7e9c1514170a0e9577c3ad61d68a1db6b573fbabf1ea9bde6296